Health
Remyelinating drug shows potential to improve vision in patients with MS – News-Medical.Net
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl)…
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl) — has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl’s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic…
-
Noosa News23 hours agoGirl on scooter dies in Laidley, motorbike rider killed in Gatton
-
Noosa News18 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
Noosa News23 hours agoGirl killed in horror e-scooter crash in Laidley, Queensland
-
General22 hours agoBrisbane coach Michael Maguire backs Reece Walsh despite error handing Broncos defeat